Skip to main content
Erschienen in: Diabetologia 9/2017

10.06.2017 | Article

High glucose increases the formation and pro-oxidative activity of endothelial microparticles

verfasst von: Dylan Burger, Maddison Turner, Fengxia Xiao, Mercedes N. Munkonda, Shareef Akbari, Kevin D. Burns

Erschienen in: Diabetologia | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Individuals with diabetes exhibit increases in circulating endothelial microparticles (eMPs, also referred to as endothelial microvesicles), which are associated with endothelial dysfunction and a heightened risk of cardiovascular complications. We have shown that eMPs are markers and mediators of vascular injury although their role in diabetes is unclear. We hypothesised that the composition and biological activity of eMPs are altered in response to high glucose exposure. We assessed the effects of high glucose on eMP formation, composition and signalling in cultured HUVECs.

Methods

eMPs were isolated from the media of HUVECs cultured under conditions of normal glucose (eMPNG), high glucose (eMPHG) or osmotic control of l-glucose (eMPLG). eMP size, concentration and surface charge were assessed by nanoparticle tracking analysis and flow cytometry. eMP protein composition was assessed by liquid chromatography–tandem mass spectrometry, and eMP-mediated effects on coagulation, reactive oxygen species (ROS) production and vessel function were assessed.

Results

Exposure of HUVECs to high glucose for 24 h caused a threefold increase in eMP formation, increased mean particle size (269 ± 18 nm vs 226 ± 11 nm) and decreased surface charge. Compared with eMPNG or eMPLG, eMPHG possessed approximately threefold greater pro-coagulant activity, stimulated HUVEC ROS production to a greater extent (~250% of eMPNG) and were more potent inhibitors of endothelial-dependent relaxation. Proteomic analysis of eMPs identified 1212 independent proteins of which 68 were exclusively found in eMPHG. Gene ontology analysis revealed that eMPHG-exclusive proteins were associated with signalling pathways related to blood coagulation, cell signalling and immune cell activation.

Conclusions/interpretation

Our results indicate that elevated glucose is a potent stimulus for eMP formation that also alters their molecular composition leading to increased bioactivity. Such effects may contribute to progressive endothelial injury and subsequent cardiovascular complications in diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM (2013) Microparticles: biomarkers and beyond. Clin Sci (Lond) 124:423–441CrossRef Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM (2013) Microparticles: biomarkers and beyond. Clin Sci (Lond) 124:423–441CrossRef
2.
Zurück zum Zitat Erdbrugger U, Le TH (2016) Extracellular vesicles in renal diseases: more than novel biomarkers? J Am Soc Nephrol 27:12–26CrossRefPubMed Erdbrugger U, Le TH (2016) Extracellular vesicles in renal diseases: more than novel biomarkers? J Am Soc Nephrol 27:12–26CrossRefPubMed
3.
Zurück zum Zitat Gyorgy B, Szabo TG, Pasztoi M et al (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68:2667–2688CrossRefPubMedPubMedCentral Gyorgy B, Szabo TG, Pasztoi M et al (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68:2667–2688CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Witwer KW, Buzas EI, Bemis LT et al (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2:20360 Witwer KW, Buzas EI, Bemis LT et al (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2:20360
5.
Zurück zum Zitat Amabile N, Rautou PE, Tedgui A, Boulanger CM (2010) Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost 36:907–916CrossRefPubMed Amabile N, Rautou PE, Tedgui A, Boulanger CM (2010) Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost 36:907–916CrossRefPubMed
6.
Zurück zum Zitat Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS (2003) Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109:175–180CrossRefPubMed Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS (2003) Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109:175–180CrossRefPubMed
7.
Zurück zum Zitat Amabile N, Guerin AP, Leroyer A et al (2005) Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16:3381–3388CrossRefPubMed Amabile N, Guerin AP, Leroyer A et al (2005) Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 16:3381–3388CrossRefPubMed
8.
Zurück zum Zitat Sinning J-M, Losch J, Walenta K, Bohm M, Nickenig G, Werner N (2011) Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 32:2034–2041CrossRefPubMed Sinning J-M, Losch J, Walenta K, Bohm M, Nickenig G, Werner N (2011) Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 32:2034–2041CrossRefPubMed
9.
Zurück zum Zitat Loyer X, Vion AC, Tedgui A, Boulanger CM (2014) Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 114:345–353CrossRefPubMed Loyer X, Vion AC, Tedgui A, Boulanger CM (2014) Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 114:345–353CrossRefPubMed
10.
Zurück zum Zitat Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS (2004) Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 286:H1910–H1915CrossRefPubMed Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS (2004) Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 286:H1910–H1915CrossRefPubMed
11.
Zurück zum Zitat Burger D, Kwart DG, Montezano AC et al (2012) Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence. J Am Heart Assoc 1:e001842CrossRefPubMedPubMedCentral Burger D, Kwart DG, Montezano AC et al (2012) Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence. J Am Heart Assoc 1:e001842CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Burger D, Montezano AC, Nishigaki N, He Y, Carter A, Touyz RM (2011) Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol 31:1898–1907CrossRefPubMed Burger D, Montezano AC, Nishigaki N, He Y, Carter A, Touyz RM (2011) Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol 31:1898–1907CrossRefPubMed
13.
Zurück zum Zitat Burger D, Turner M, Munkonda MN, Touyz RM (2016) Endothelial microparticle-derived reactive oxygen species: role in endothelial signaling and vascular function. Oxidative Med Cell Longev 2016:5047954CrossRef Burger D, Turner M, Munkonda MN, Touyz RM (2016) Endothelial microparticle-derived reactive oxygen species: role in endothelial signaling and vascular function. Oxidative Med Cell Longev 2016:5047954CrossRef
14.
Zurück zum Zitat Schock SC, Edrissi H, Burger D, Cadonic R, Hakim A, Thompson C (2014) Microparticles generated during chronic cerebral ischemia deliver proapoptotic signals to cultured endothelial cells. Biochem Biophys Res Commun 450:912–917CrossRefPubMed Schock SC, Edrissi H, Burger D, Cadonic R, Hakim A, Thompson C (2014) Microparticles generated during chronic cerebral ischemia deliver proapoptotic signals to cultured endothelial cells. Biochem Biophys Res Commun 450:912–917CrossRefPubMed
15.
Zurück zum Zitat Peterson DB, Sander T, Kaul S et al (2008) Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics 8:2430–2446CrossRefPubMedPubMedCentral Peterson DB, Sander T, Kaul S et al (2008) Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics 8:2430–2446CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Agouni A, Ducluzeau P-H, Benameur T et al (2011) Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice. PLoS One 6:e27809CrossRefPubMedPubMedCentral Agouni A, Ducluzeau P-H, Benameur T et al (2011) Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice. PLoS One 6:e27809CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Jansen F, Yang X, Franklin BS et al (2013) High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. Cardiovasc Res 98:94–106CrossRefPubMed Jansen F, Yang X, Franklin BS et al (2013) High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. Cardiovasc Res 98:94–106CrossRefPubMed
18.
Zurück zum Zitat Jansen F, Wang H, Przybilla D et al (2016) Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus. Cardiovasc Diabetol 15:49CrossRefPubMedPubMedCentral Jansen F, Wang H, Przybilla D et al (2016) Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus. Cardiovasc Diabetol 15:49CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Burger D, Vinas JL, Akbari S et al (2015) Human endothelial colony-forming cells protect against acute kidney injury: role of exosomes. Am J Pathol 185:2309–2323CrossRefPubMed Burger D, Vinas JL, Akbari S et al (2015) Human endothelial colony-forming cells protect against acute kidney injury: role of exosomes. Am J Pathol 185:2309–2323CrossRefPubMed
20.
Zurück zum Zitat Lytvyn Y, Xiao F, Kennedy CR et al (2017) Assessment of urinary microparticles in normotensive patients with type 1 diabetes. Diabetologia 60:581–584CrossRefPubMed Lytvyn Y, Xiao F, Kennedy CR et al (2017) Assessment of urinary microparticles in normotensive patients with type 1 diabetes. Diabetologia 60:581–584CrossRefPubMed
21.
Zurück zum Zitat Burger D, Gagnon A, Lochnan HA, Mahzari M, Sorisky A (2015) Thyroid-stimulating hormone acutely increases levels of circulating pro-coagulant microparticles. Clin Endocrinol 83:285–287CrossRef Burger D, Gagnon A, Lochnan HA, Mahzari M, Sorisky A (2015) Thyroid-stimulating hormone acutely increases levels of circulating pro-coagulant microparticles. Clin Endocrinol 83:285–287CrossRef
22.
23.
Zurück zum Zitat Briones AM, Nguyen Dinh Cat A, Callera GE et al (2012) Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 59:1069–1078CrossRefPubMed Briones AM, Nguyen Dinh Cat A, Callera GE et al (2012) Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 59:1069–1078CrossRefPubMed
24.
Zurück zum Zitat Xiao F, Zimpelmann J, Agaybi S, Gurley SB, Puente L, Burns KD (2014) Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells. PLoS One 9:e85958CrossRefPubMedPubMedCentral Xiao F, Zimpelmann J, Agaybi S, Gurley SB, Puente L, Burns KD (2014) Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells. PLoS One 9:e85958CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Hahne H, Pachl F, Ruprecht B et al (2013) DMSO enhances electrospray response, boosting sensitivity of proteomic experiments. Nat Methods 10:989–991CrossRefPubMed Hahne H, Pachl F, Ruprecht B et al (2013) DMSO enhances electrospray response, boosting sensitivity of proteomic experiments. Nat Methods 10:989–991CrossRefPubMed
26.
Zurück zum Zitat Bindea G, Mlecnik B, Hackl H et al (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25:1091–1093CrossRefPubMedPubMedCentral Bindea G, Mlecnik B, Hackl H et al (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25:1091–1093CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504CrossRefPubMedPubMedCentral Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Feng B, Chen Y, Luo Y, Chen M, Li X, Ni Y (2010) Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis 208:264–269CrossRefPubMed Feng B, Chen Y, Luo Y, Chen M, Li X, Ni Y (2010) Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis 208:264–269CrossRefPubMed
29.
Zurück zum Zitat Sabatier F, Darmon P, Hugel B et al (2002) Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51:2840–2845CrossRefPubMed Sabatier F, Darmon P, Hugel B et al (2002) Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51:2840–2845CrossRefPubMed
30.
Zurück zum Zitat Connor DE, Exner T, Ma DD, Joseph JE (2009) Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagul Fibrinolysis 20:558–564CrossRefPubMed Connor DE, Exner T, Ma DD, Joseph JE (2009) Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagul Fibrinolysis 20:558–564CrossRefPubMed
31.
Zurück zum Zitat Morel O, Toti F, Hugel B, Freyssinet JM (2004) Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 11:156–164CrossRefPubMed Morel O, Toti F, Hugel B, Freyssinet JM (2004) Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 11:156–164CrossRefPubMed
32.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853CrossRef UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853CrossRef
33.
Zurück zum Zitat Lopes-Virella MF, Carter RE, Gilbert GE et al (2008) Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care 31:2006–2012CrossRefPubMedPubMedCentral Lopes-Virella MF, Carter RE, Gilbert GE et al (2008) Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care 31:2006–2012CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Polak JF, Backlund J-YC, Cleary PA et al (2011) Progression of carotid artery intima-media thickness during 12 years in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. Diabetes 60:607–613CrossRefPubMedPubMedCentral Polak JF, Backlund J-YC, Cleary PA et al (2011) Progression of carotid artery intima-media thickness during 12 years in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. Diabetes 60:607–613CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Koga H, Sugiyama S, Kugiyama K et al (2005) Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 45:1622–1630CrossRefPubMed Koga H, Sugiyama S, Kugiyama K et al (2005) Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 45:1622–1630CrossRefPubMed
36.
Zurück zum Zitat Cheng V, Kashyap SR, Schauer PR, Kirwan JP, McCrae KR (2013) Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles. Surg Obes Relat Dis 9:207–212CrossRefPubMed Cheng V, Kashyap SR, Schauer PR, Kirwan JP, McCrae KR (2013) Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles. Surg Obes Relat Dis 9:207–212CrossRefPubMed
37.
Zurück zum Zitat Esposito K, Maiorino MI, Di Palo C et al (2011) Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes—a randomized controlled trial. Diabetes Obes Metab 13:439–445CrossRefPubMed Esposito K, Maiorino MI, Di Palo C et al (2011) Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes—a randomized controlled trial. Diabetes Obes Metab 13:439–445CrossRefPubMed
38.
Zurück zum Zitat Burger D, Thibodeau JF, Holterman CE, Burns KD, Touyz RM, Kennedy CR (2014) Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury. J Am Soc Nephrol 25:1401–1407CrossRefPubMedPubMedCentral Burger D, Thibodeau JF, Holterman CE, Burns KD, Touyz RM, Kennedy CR (2014) Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury. J Am Soc Nephrol 25:1401–1407CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Ettelaie C, Su S, Li C, Collier ME (2008) Tissue factor-containing microparticles released from mesangial cells in response to high glucose and AGE induce tube formation in microvascular cells. Microvasc Res 76:152–160CrossRefPubMed Ettelaie C, Su S, Li C, Collier ME (2008) Tissue factor-containing microparticles released from mesangial cells in response to high glucose and AGE induce tube formation in microvascular cells. Microvasc Res 76:152–160CrossRefPubMed
40.
Zurück zum Zitat Terrisse AD, Puech N, Allart S et al (2010) Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow. J Thromb Haemost 8:2810–2819CrossRefPubMed Terrisse AD, Puech N, Allart S et al (2010) Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow. J Thromb Haemost 8:2810–2819CrossRefPubMed
41.
Zurück zum Zitat Zu L, Niu C, Li J, et al. (2015) Proteomic research of high-glucose-activated endothelial microparticles and related proteins to Alzheimer’s disease. Diab Vasc Dis Res 12:467–470 Zu L, Niu C, Li J, et al. (2015) Proteomic research of high-glucose-activated endothelial microparticles and related proteins to Alzheimer’s disease. Diab Vasc Dis Res 12:467–470
42.
Zurück zum Zitat Aird WC (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100:158–173CrossRefPubMed Aird WC (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100:158–173CrossRefPubMed
43.
Zurück zum Zitat Amabile N, Guerin AP, Tedgui A, Boulanger CM, London GM (2012) Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dial Transplant 27:1873–1880CrossRefPubMed Amabile N, Guerin AP, Tedgui A, Boulanger CM, London GM (2012) Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dial Transplant 27:1873–1880CrossRefPubMed
Metadaten
Titel
High glucose increases the formation and pro-oxidative activity of endothelial microparticles
verfasst von
Dylan Burger
Maddison Turner
Fengxia Xiao
Mercedes N. Munkonda
Shareef Akbari
Kevin D. Burns
Publikationsdatum
10.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 9/2017
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4331-2

Weitere Artikel der Ausgabe 9/2017

Diabetologia 9/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.